Although both Novel Retatrutide and Hyalgan Durolane target joint pain , their methods of function are distinctly varied . Novo Nordisk's Retatrutide is a double agonist influencing glucagon-like peptide-1 and the GIP receptor, primarily used for body regulation, which may secondarily alleviate swe